Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BJOG ; 116(11): 1481-91, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19583715

RESUMO

OBJECTIVE: To describe obstetric intervention for extremely preterm births in ten European regions and assess its impact on mortality and short term morbidity. DESIGN: Prospective observational cohort study. SETTING: Ten regions from nine countries participating in the 'Models of Organising Access to Intensive Care for Very Preterm Babies in Europe' (MOSAIC) project. POPULATION: All births from 22 to 29 weeks of gestation (n = 4146) in 2003, excluding terminations of pregnancy. METHODS: Comparison of three obstetric interventions (antenatal corticosteroids, antenatal transfer and caesarean section for fetal indication) rates at 22-23, 24-25 and 26-27 weeks to that at 28-29 weeks and the association of the level of intervention with pregnancy outcome. MAIN OUTCOME MEASURES: Use of antenatal corticosteroids, antenatal transfer and caesarean section by two-week gestational age groups as well as a composite score of these three interventions. Outcomes included stillbirth, in-hospital mortality and intraventricular haemorrhage (IVH) grades III and IV and/or periventricular leucomalacia (PVL) and bronchopulmonary dysplasia (BPD). RESULTS: There were large differences between regions in interventions for births at 22-23 and 24-25 weeks. Differences were most pronounced at 24-25 weeks; in some regions these babies received the same care as babies of 28-29 weeks, whereas elsewhere levels of intervention were distinctly lower. Before 26 weeks and especially at 24-25 weeks, there was an association between the composite intervention score and mortality. No association was observed at 26-27 weeks. For survivors at 24-25 weeks, the intervention score was associated with higher rates of BPD, but not with IVH or PVL. CONCLUSIONS: There are large differences between European regions in obstetric practices at the lower limit of viability and these are related to outcome, especially at 24-25 weeks.


Assuntos
Doenças do Prematuro/terapia , Recém-Nascido Prematuro , Terapia Intensiva Neonatal/estatística & dados numéricos , Nascimento Prematuro/epidemiologia , Corticosteroides/administração & dosagem , Displasia Broncopulmonar/epidemiologia , Displasia Broncopulmonar/terapia , Hemorragia Cerebral/epidemiologia , Hemorragia Cerebral/terapia , Europa (Continente)/epidemiologia , Feminino , Idade Gestacional , Mortalidade Hospitalar , Humanos , Recém-Nascido , Doenças do Prematuro/epidemiologia , Leucomalácia Periventricular/epidemiologia , Leucomalácia Periventricular/terapia , Transferência de Pacientes , Gravidez , Resultado da Gravidez , Estudos Prospectivos , Natimorto/epidemiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA